HOUSTON, TEXAS / ACCESS Newswire / January 28, 2025 / The Mayan Languages Preservation and Digitization Project, supported by ...

According to Business Research Insights the Portable Home Ventilator Market expected to exhibit a CAGR of 10.5% by 2033.The ...

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...

Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, ...

Isomerase has formed a strategic partnership with BugBiome, which is focused on the discovery of novel targeted ...

Thermo Fisher Scientific, the world leader in serving science, today announced the introduction of Olink® Reveal, setting a ...

This is Dermata's first issued U.S. patent for XYNGARI™, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI™ ...

AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, ...

SACRAMENTO, CALIFORNIA / ACCESS Newswire / January 28, 2025 / Paragon Health IT announced a strategic reorganization effective January 1, 2025. As part of this reorganization, Paragon Health IT will ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...

GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...

AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process development, is pleased to announce the appointment of Dr.